… We investigate a cohort of SARS-CoV-2-naïve and COVID-19-convalescent individuals
immediately after vaccination and 6 months later. We use different enzyme-linked …

… Since the absence of antibodies does not equate to absence of immune memory, we … B
cells in convalescent individuals. Here, we report a longitudinal assessment of humoral immune …

… Understanding humoral immune responses to SARS-CoV-2 infection will play a critical
role … We report systemic and mucosal antibody responses in convalescent individuals who …

… sustainability of protective immunity of convalescent COVID-19 patients is one of the most
urgent issues. If existent, convalescent individuals could benefit from their immunity to serve at …

… This study indicated that individuals in the convalescent phase of COVID-19 were found to
have robust humoral immunity even 12 months after infection, although the patient's history …

… concern was the development of humoral immunity in COVID-19 convalescent subjects.
Studies in people without MS indicated that the majority of convalescent COVID-19 subjects …

… A decline in the antibody response to severe acute respiratory syndrome coronavirus 2 (…
month, increases the risk of reinfection for convalescent individuals. There is a current need to …

… Understanding humoral immune responses to SARS-CoV-2 … responses in convalescent
individuals who experienced … endemic CoV were observed among convalescent donors. SARS-…

… persistent humoral immunity in COVID-19–convalescent individuals by targeting dominant
epitopes located at the spike and ORF1ab proteins that mediate long-term immune responses…

… To summarize the results, absence of humoral immunity was more frequent in ocrelizumab
treated pwMS in convalescent and vaccinated groups compared to HC and TN/1st pwMS. No …